<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03098641</url>
  </required_header>
  <id_info>
    <org_study_id>2016/P05/179</org_study_id>
    <nct_id>NCT03098641</nct_id>
  </id_info>
  <brief_title>Smartmesh Technology in Pelvic Floor Repair Procedures</brief_title>
  <acronym>Restorelle</acronym>
  <official_title>Etude rétrospective Chez Des Patientes opérées d'un Prolapsus génital Avec l'Implant de Renfort Restorelle Direct Fix : à Propos Des premières Poses en France Entre Janvier 2013 et décembre 2016 (Restorelle).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier de la Rochelle Ré Aunis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Hospitalier de la Rochelle Ré Aunis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pelvic organ prolapse repair involves conservative treatments and surgical treatments.
      Conservative treatments are for patients with moderate prolapse. Treatment of symptomatic
      prolapse remains essentially surgical. According to detailed medical history and a thorough
      physical exam, surgical techniques may be performed by high abdominal, low vaginal or mixed
      routes with or without the use of a reinforcing implant. Restorelle Direct Fix is indicated
      for transvaginal anterior and posterior surgical repair either as mechanical support or as
      reinforcement of pelvic floor defects. Advantages and disadvantages of vaginal prostheses are
      known but only limited data have been reported on the use of Restorelle® in the treatment of
      pelvic organ prolapse. This study is designed to collect data on the safety and efficacy of
      Restorelle® Direct Fix in pelvic organ prolapse repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Between January 2013 and December 2016, in the participating centers, all adult women who
      underwent surgery to repair pelvic organ prolapse (recurrent or not) through the vagina with
      the addition of anterior and/or posterior Restorelle Direct Fix prosthesis are eligible.
      Collected data are about the peri-operative period and the data available at the last
      consultation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with a composite outcome : bladder wound, rectum wound, abnormal bleeding</measure>
    <time_frame>up to 30 days after surgery</time_frame>
    <description>Perioperative morbidity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with early complications</measure>
    <time_frame>up to 30 days after surgery</time_frame>
    <description>Urinary retention, urinary tract infection, hematoma, ureteral complication, second surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with late complications</measure>
    <time_frame>up to 4 years after surgery</time_frame>
    <description>self-catheterization, recurrent urinary tract infections, de novo urinary stress incontinence, chronic pain, vaginal prosthesis exposure, prolapse recurrence, secondary surgery, other</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic organ prolapse quantification (POP-Q) exam before surgery</measure>
    <time_frame>preoperative, within 48 hours before surgery</time_frame>
    <description>POP-Q Staging Criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic organ prolapse quantification (POP-Q) exam after surgery</measure>
    <time_frame>up to 4 years after surgery</time_frame>
    <description>POP-Q Staging Criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with preoperative urinary signs</measure>
    <time_frame>within 4 weeks before surgery</time_frame>
    <description>urinary stress incontinence, overactive bladder, dysuria, masked urinary incontinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with postoperative urinary signs</measure>
    <time_frame>up to 4 years after surgery</time_frame>
    <description>urinary stress incontinence, overactive bladder, dysuria, masked urinary incontinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with preoperative digestive signs</measure>
    <time_frame>within 4 weeks before surgery</time_frame>
    <description>dyschezia, incontinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with postoperative digestive signs</measure>
    <time_frame>up to 4 years after surgery</time_frame>
    <description>dyschezia, incontinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with preoperative active sexuality</measure>
    <time_frame>within 4 weeks before surgery</time_frame>
    <description>Patients reporting active sexuality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with preoperative dyspareunia</measure>
    <time_frame>within 4 weeks before surgery</time_frame>
    <description>Patients reporting pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with postoperative active sexuality</measure>
    <time_frame>up to 4 years after surgery</time_frame>
    <description>Patients reporting active sexuality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with postoperative dyspareunia</measure>
    <time_frame>up to 4 years after surgery</time_frame>
    <description>Patients reporting pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative score at Numeric Pain Rating Scale</measure>
    <time_frame>Within 48 hours before surgery</time_frame>
    <description>The numeric pain rating scale ranges from 0 (no pain) to 10 (worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative score at Numeric Pain Rating Scale</measure>
    <time_frame>up to 48 hours after surgery</time_frame>
    <description>The numeric pain rating scale ranges from 0 (no pain) to 10 (worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction score</measure>
    <time_frame>up to 4 years after surgery</time_frame>
    <description>The numeric satisfaction scale ranges from 1 (very satisfied) to 7 (very dissatisfied)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pelvic organ prolapse repair</intervention_name>
    <description>Surgery to repair pelvic organ prolapse through the vagina using stitches with the addition of surgical mesh.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult women who underwent surgery to repair pelvic organ prolapse (recurrent or not)
        through the vagina with the addition of anterior and/or posterior Restorelle Direct Fix
        prosthesis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18

          -  woman who underwent surgery to repair pelvic organ prolapse (recurrent or not) through
             the vagina with the addition of anterior and/or posterior Restorelle Direct Fix
             prosthesis

          -  informed and not opposed to the use of her data

        Exclusion Criteria:

          -  Opposed to the use of her data
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Ferry, MD</last_name>
    <role>Study Director</role>
    <affiliation>Groupe Hospitalier de la Rochelle Ré Aunis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caroline ALLIX-BEGUEC, Ph.D.</last_name>
    <phone>+33 (0) 516 49 42 46</phone>
    <email>caroline.allix-beguec@ch-larochelle.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CH Dunkerque</name>
      <address>
        <city>Grande Synthe</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe DEBODINANCE, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier de la Rochelle Ré Aunis</name>
      <address>
        <city>La Rochelle</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Ferry, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Ame</name>
      <address>
        <city>Lambres-lez-Douai</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric DEDECKER, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Laon</name>
      <address>
        <city>Laon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre NTSHAYKOLO, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Jules Verne</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe POCHOLLE, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Nîmes</name>
      <address>
        <city>Nimes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renaud DE TAYRAC, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital des Diaconesses</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Etienne VINCENS, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Kremlin-Bicêtre</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé FERNANDEZ, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Cornouaille</name>
      <address>
        <city>Quimper</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas WONG CHI MAN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique St Michel et St Anne</name>
      <address>
        <city>Quimper</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yves COADOU, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Polyclinique de Courlancy</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe VILLENA, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique la Sagesse</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Louis BROUX, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Robert Pax</name>
      <address>
        <city>Sarreguemines</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Issam AYZOUKI, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Agyl</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David HAMID, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adrien VIDART, MD</last_name>
    </contact>
    <investigator>
      <last_name>Florence COUR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux du Léman</name>
      <address>
        <city>Thonon les Bains</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco DEL PIANO, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.afnor.org/</url>
    <description>Association Française de Normalisation (AFNOR). Norme Française (NF) S 94-801 implants de renfort mis en place par voie vaginale pour cure d'incontinence urinaire d'effort et/ou de prolapsus des organes pelviens. Essais pré-cliniques et essais cliniques</description>
  </link>
  <reference>
    <citation>Le Normand L, Cosson M, Cour F, Deffieux X, Donon L, Ferry P, Fatton B, Hermieu JF, Marret H, Meurette G, Cortesse A, Wagner L, Fritel X. [Clinical practice guidelines: Summary of recommendations for first surgical treatment of female pelvic organ prolapse by 5 French academic societies: AFU, CNGOF, SIFUD-PP, SNFCP, and SCGP]. Prog Urol. 2016 Jul;26 Suppl 1:S1-7. doi: 10.1016/S1166-7087(16)30424-9. Review. French.</citation>
    <PMID>27595623</PMID>
  </reference>
  <reference>
    <citation>Khunda A, Vashisht A, Cutner A. New procedures for uterine prolapse. Best Pract Res Clin Obstet Gynaecol. 2013 Jun;27(3):363-79. doi: 10.1016/j.bpobgyn.2012.12.004. Epub 2013 Jan 5. Review.</citation>
    <PMID>23298608</PMID>
  </reference>
  <reference>
    <citation>Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997 Apr;89(4):501-6.</citation>
    <PMID>9083302</PMID>
  </reference>
  <reference>
    <citation>Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ; Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008 Sep 17;300(11):1311-6. doi: 10.1001/jama.300.11.1311.</citation>
    <PMID>18799443</PMID>
  </reference>
  <reference>
    <citation>Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP-Q) - a new era in pelvic prolapse staging. J Med Life. 2011 Jan-Mar;4(1):75-81. Epub 2011 Feb 25.</citation>
    <PMID>21505577</PMID>
  </reference>
  <reference>
    <citation>Lousquy R, Costa P, Delmas V, Haab F. [Update on the epidemiology of genital prolapse]. Prog Urol. 2009 Dec;19(13):907-15. doi: 10.1016/j.purol.2009.09.011. Epub 2009 Nov 4. Review. French.</citation>
    <PMID>19969258</PMID>
  </reference>
  <reference>
    <citation>Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Marjoribanks J. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. Cochrane Database Syst Rev. 2016 Feb 9;2:CD012079. doi: 10.1002/14651858.CD012079. Review.</citation>
    <PMID>26858090</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2017</study_first_submitted>
  <study_first_submitted_qc>March 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>June 16, 2017</last_update_submitted>
  <last_update_submitted_qc>June 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>January 23, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

